HighLife Receives IDE Approval to Initiate US Pivotal Clinical Study for treatment of Mitral Regurgitation
HighLife receives IDE approval to initiate US pivotal clinical study for treatment of mitral regurgitation
Stay updated with breaking news from Icahn School. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HighLife receives IDE approval to initiate US pivotal clinical study for treatment of mitral regurgitation
Avoid some of the stress of traveling with toddlers and let your partner board before you and the kids on your next airplane ride.
ASCO 2024 molecular testing to guide perioperative systemic therapy for urothelial cancer, ctDNA testing, adjuvant immune checkpoint blockade, TOMBOLA trial.
Scientists have found the genetic root of a disorder that causes intellectual disability, which they estimate affects as many as one in 20,000 young people.
This technology could be applied across psychiatry, and plausibly in other fields of medicine